Skip to Content

OWC Pharmaceutical Research Corp OWCP

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

OWCP is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$5.74
Uncertainty
Extreme
1-Star Price
$6.42
5-Star Price
$7.36
Economic Moat
Ghpzk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OWCP is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$497.50
Volume/Avg
500 / 16,515

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
3

Valuation

Metric
OWCP
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
OWCP
Quick Ratio
2.70
Current Ratio
3.12
Interest Coverage
Quick Ratio
OWCP

Profitability

Metric
OWCP
Return on Assets (Normalized)
−73.66%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
OWCP
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
XhszclvzLbjx$82.1 Bil
Merck KGaA ADR
MKKGY
DspckjlsxpRwndxd$73.2 Bil
Haleon PLC ADR
HLN
ThcsfszlDxgq$41.0 Bil
Viatris Inc
VTRS
FdmkgdyzXbcq$14.4 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
WdpfzfkvBjbkn$13.7 Bil
Catalent Inc
CTLT
StzwfwnpjDmjsvj$10.6 Bil
Perrigo Co PLC
PRGO
JkqwdkvVpcw$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
XlzpgdgzCtvhsyn$3.5 Bil
Curaleaf Holdings Inc
CURLF
QgnrgvttVmfn$3.0 Bil
Green Thumb Industries Inc
GTBIF
ZmcjtxjvlXcny$2.7 Bil

Sponsor Center